NeuroSense Therapeutics NRSN Income Statement (2020-2026)

NASDAQ NRSN
$2.60 +0.21 (+8.79%)
As of: Oct 21, 2026 · 1:19 PM EDT
Reported Financials

NeuroSense Therapeutics Quarterly Income Statement

Periods 17 quarters
Latest Jun 2026

NeuroSense Therapeutics income statement data for the quarter ended Jun 2026. This income statement covers 17 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Research & DevelopmentR&D 4.43M-1.30M4.46M-8.04M10.46M-1.85M5.66M-9.18M12.64M-1.88M5.62M-8.35M10.31M
Selling, General & AdministrativeSG&A 2.50M-1.97M5.66M-8.99M10.27M-1.14M3.69M-6.17M8.39M-1.11M3.40M-5.81M7.72M
Operating ExpensesOpex 6.93M-3.26M10.12M-17.03M20.73M-2.99M9.35M-15.35M21.04M-2.99M9.02M-14.16M18.03M
Operating IncomeOp. Inc 0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
EBIT 0.96M-3.26M-3.59M-3.32M-0.38M-2.99M-3.37M-2.63M-3.06M-2.99M-3.03M-2.11M-1.77M
Non-operating items
Non Operating Interest Expenses 1.19M-0.02M0.08M-0.13M0.11M-0.31M2.51M-4.40M4.42M
Interest & Investment IncomeInt & Inv Inc 2.73M0.57M0.14M0.34M0.21M0.06M0.14M3.69M0.34M
Non Operating IncomeNon Op. Inc. 0.55M0.11M0.07M-0.28M2.28M-0.13M-2.41M2.17M-0.04M-0.03M
Net income details
EBT 2.50M-2.67M-3.53M-2.86M-0.29M-2.62M-5.74M5.47M-7.14M-2.99M-3.03M-2.11M-1.77M
Profit After TaxPAT 2.50M-2.67M-3.53M-2.86M-0.29M-2.62M-5.74M5.47M-7.14M-2.99M-3.03M-2.11M-1.77M
Income from Continuing OperationsIncome (Continuing) 2.50M-2.67M-3.53M-2.86M-0.29M-2.62M-5.74M5.47M-7.14M-2.99M-3.03M-2.11M-1.77M
Consolidated Net IncomeConsol Net Inc. 2.50M-2.67M-3.53M-2.86M-0.29M-2.62M-5.74M5.47M-7.14M-2.99M-3.03M-2.11M-1.77M
Income towards Parent CompanyParent Net Inc 0.72M-2.72M-3.48M-2.99M-1.30M-2.92M-3.65M-0.35M-3.19M-5.40M-0.86M-2.15M-1.80M
Net Income towards Common StockholdersNet Income 0.72M-2.72M-3.48M-2.99M-1.30M-2.92M-3.65M-0.35M-3.19M-5.40M-0.86M-2.15M-1.80M
Additional items
EPS (Basic) 2.31-8.70-11.15-9.59-2.26-5.08-6.34-0.61-4.67-7.92-1.26-3.15-1.94
EPS (Diluted) -2.26-5.08-6.34-0.61-4.67-7.92-1.26-3.15-1.94
Shares Outstanding 0.28M0.31M0.31M0.31M0.31M0.58M0.58M0.58M0.58M0.68M0.68M0.68M0.68M0.93M0.93M1.27M1.27M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.58M0.58M0.58M0.58M0.68M0.68M0.68M0.68M0.93M0.93M1.27M1.27M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.28M0.55M0.59M0.77M1.16M1.63M
Interest ExpensesInt Expense 1.19M-0.02M0.08M-0.13M0.11M-0.31M2.51M-4.40M4.42M

NeuroSense Therapeutics Income Statement API

Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NRSN&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY